Erlotinib 100 mg and 150 mg Tablets – Cancer Medicines Supplier

ERLOTINIB USES

Erlotinib is an oral anti cancer drug which is taken by mouth once a day, at least 1 hour before or 2 hours after eating. It is a member of the Epidermal Growth Factor Receptor (EGFR) inhibitor class of agents and currently indicated for treatment of advanced-stage Non-Small Cell Lung Cancer (NSCLC) and pancreatic cancer.

Different treatments work for different types of lung cancer. To decide treatment with Erlotinib for a particular patient, doctors look at:

• The type of cancer the patient has
• The patient’s age and overall health
• The stage the lung cancer is at — whether it has spread to other parts of the body

After looking at those things, doctors may recommend you Erlotinib Cancer Medicines.

ERLOTINIB AVAILABLE BRANDS ARE:

• Erlocip 100 mg Erlotinib Tablet
• Erlonat 100 mg Erlotinib Tablet
• Erlocip 150 mg Erlotinib Tablets
• Erlonat 150 mg Erlotinib Tablets

Please see the Erlotinib full Product Information at www.oddwayinternational.com for additional Important Safety Information.